MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

Armed with positive results in two phase 3 trials, MSD is poised to be the first drugmaker to file for approval of an oral PCSK9 inhibitor for lowering cholesterol. Top-line results from the CORALreef ...

President Trump announced new tariffs on pharmaceuticals, heavy trucks and furniture, including a 100% duty on patented drugs, unless the producer is building a manufacturing plant in the US. Thursday ...

President Trump floated using revenue the US has accrued from his tariffs to offer bailouts to farmers struggling with the early effects of the duties. Trump said farmers are, "for a little while, ...